![Standards should be applied in the prevention and handling of missing data for patient-centered outcomes research: a systematic review and expert consensus - Journal of Clinical Epidemiology Standards should be applied in the prevention and handling of missing data for patient-centered outcomes research: a systematic review and expert consensus - Journal of Clinical Epidemiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/2022611476/2042805229/gr1.jpg)
Standards should be applied in the prevention and handling of missing data for patient-centered outcomes research: a systematic review and expert consensus - Journal of Clinical Epidemiology
![A hybrid approach of handling missing data under different missing data mechanisms: VISIBLE 1 and VARSITY trials for ulcerative colitis - ScienceDirect A hybrid approach of handling missing data under different missing data mechanisms: VISIBLE 1 and VARSITY trials for ulcerative colitis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1551714420303049-gr3.jpg)
A hybrid approach of handling missing data under different missing data mechanisms: VISIBLE 1 and VARSITY trials for ulcerative colitis - ScienceDirect
![Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide - Cro - 2020 - Statistics in Medicine - Wiley Online Library Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide - Cro - 2020 - Statistics in Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/553e5899-0fe0-4c03-9a0e-cf13ae6ab18c/sim8569-fig-0003-m.jpg)
Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide - Cro - 2020 - Statistics in Medicine - Wiley Online Library
![Quality of missing data reporting and handling in palliative care trials demonstrates that further development of the CONSORT statement is required: a systematic review - Journal of Clinical Epidemiology Quality of missing data reporting and handling in palliative care trials demonstrates that further development of the CONSORT statement is required: a systematic review - Journal of Clinical Epidemiology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6f1cc936-4bb1-4c94-86ac-07f9219b05ad/gr1_lrg.jpg)
Quality of missing data reporting and handling in palliative care trials demonstrates that further development of the CONSORT statement is required: a systematic review - Journal of Clinical Epidemiology
![Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models - Ratitch - 2013 - Pharmaceutical Statistics - Wiley Online Library Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models - Ratitch - 2013 - Pharmaceutical Statistics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/5f6e077f-75bc-4eba-8d4d-289ad9263722/pst1549-fig-0001-m.jpg)
Missing data in clinical trials: from clinical assumptions to statistical analysis using pattern mixture models - Ratitch - 2013 - Pharmaceutical Statistics - Wiley Online Library
![An Empirical Comparison of Statistical Methods for Missing Data in Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Trials for Chronic Pain and Lipid-Lowering Products | SpringerLink An Empirical Comparison of Statistical Methods for Missing Data in Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Trials for Chronic Pain and Lipid-Lowering Products | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs43441-020-00168-6/MediaObjects/43441_2020_168_Fig1_HTML.png)
An Empirical Comparison of Statistical Methods for Missing Data in Randomized, Double-Blind, Placebo-Controlled, Phase 3 Clinical Trials for Chronic Pain and Lipid-Lowering Products | SpringerLink
![A narrative review of estimands in drug development and regulatory evaluation: old wine in new barrels? | Trials | Full Text A narrative review of estimands in drug development and regulatory evaluation: old wine in new barrels? | Trials | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-020-04546-1/MediaObjects/13063_2020_4546_Fig1_HTML.png)
A narrative review of estimands in drug development and regulatory evaluation: old wine in new barrels? | Trials | Full Text
![Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring - ESMO Open Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring - ESMO Open](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/f0eed4ba-225a-4f72-b943-585d7e3b6d28/gr1_lrg.jpg)
Biases in study design, implementation, and data analysis that distort the appraisal of clinical benefit and ESMO-Magnitude of Clinical Benefit Scale (ESMO-MCBS) scoring - ESMO Open
![A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic | BMC Medical Research Methodology | Full Text A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-020-01089-6/MediaObjects/12874_2020_1089_Fig2_HTML.png)
A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic | BMC Medical Research Methodology | Full Text
![On Biostatistics and Clinical Trials: Single Imputation Methods for Missing Data: LOCF, BOCF, LRCF (Last Rank Carried Forward), and NOCB (Next Observation Carried Backward) On Biostatistics and Clinical Trials: Single Imputation Methods for Missing Data: LOCF, BOCF, LRCF (Last Rank Carried Forward), and NOCB (Next Observation Carried Backward)](https://lh3.googleusercontent.com/-spkc6qLufmc/X_HslF2AAZI/AAAAAAAADno/60aeOIAhfo8Db9F38rXjbUteMILRs8GPwCLcBGAsYHQ/w523-h304/image.png)
On Biostatistics and Clinical Trials: Single Imputation Methods for Missing Data: LOCF, BOCF, LRCF (Last Rank Carried Forward), and NOCB (Next Observation Carried Backward)
![Missing data in trial‐based cost‐effectiveness analysis: An incomplete journey - Leurent - 2018 - Health Economics - Wiley Online Library Missing data in trial‐based cost‐effectiveness analysis: An incomplete journey - Leurent - 2018 - Health Economics - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4d6011bc-decd-459b-b82d-84fe20cdf4ae/hec3654-fig-0003-m.jpg)
Missing data in trial‐based cost‐effectiveness analysis: An incomplete journey - Leurent - 2018 - Health Economics - Wiley Online Library
![A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic | BMC Medical Research Methodology | Full Text A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic | BMC Medical Research Methodology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12874-020-01089-6/MediaObjects/12874_2020_1089_Fig1_HTML.png)
A four-step strategy for handling missing outcome data in randomised trials affected by a pandemic | BMC Medical Research Methodology | Full Text
![Quality of missing data reporting and handling in palliative care trials demonstrates that further development of the CONSORT statement is required: a systematic review - ScienceDirect Quality of missing data reporting and handling in palliative care trials demonstrates that further development of the CONSORT statement is required: a systematic review - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0895435616304735-gr2.jpg)
Quality of missing data reporting and handling in palliative care trials demonstrates that further development of the CONSORT statement is required: a systematic review - ScienceDirect
![PDF) The Prevention and Treatment of Missing Data in Clinical Trials | Texila International Journal - Academia.edu PDF) The Prevention and Treatment of Missing Data in Clinical Trials | Texila International Journal - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/51789264/mini_magick20190124-19274-hb38wx.png?1548355460)
PDF) The Prevention and Treatment of Missing Data in Clinical Trials | Texila International Journal - Academia.edu
![Guideline on Missing Data in Confirmatory Clinical Trials / guideline-on- missing-data-in-confirmatory-clinical-trials.pdf / PDF4PRO Guideline on Missing Data in Confirmatory Clinical Trials / guideline-on- missing-data-in-confirmatory-clinical-trials.pdf / PDF4PRO](https://pdf4pro.com/cache/preview/b/0/9/c/c/3/b/6/thumb-b09cc3b6f82bfd67bc0d790d20a33f54.jpg)
Guideline on Missing Data in Confirmatory Clinical Trials / guideline-on- missing-data-in-confirmatory-clinical-trials.pdf / PDF4PRO
![Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide - Cro - 2020 - Statistics in Medicine - Wiley Online Library Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide - Cro - 2020 - Statistics in Medicine - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/fb8cdfbb-2dcb-4e3c-ba6f-9ca8598b505f/sim.v39.21.cover.jpg)
Sensitivity analysis for clinical trials with missing continuous outcome data using controlled multiple imputation: A practical guide - Cro - 2020 - Statistics in Medicine - Wiley Online Library
Full article: Statistical Issues and Recommendations for Clinical Trials Conducted During the COVID-19 Pandemic
![Considerations to address missing data when deriving clinical trial endpoints from digital health technologies - ScienceDirect Considerations to address missing data when deriving clinical trial endpoints from digital health technologies - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1551714421003979-gr1.jpg)
Considerations to address missing data when deriving clinical trial endpoints from digital health technologies - ScienceDirect
![Empirical evaluation of the implementation of the EMA guideline on missing data in confirmatory clinical trials: Specification of mixed models for longitudinal data in study protocols - Häckl - 2019 - Pharmaceutical Empirical evaluation of the implementation of the EMA guideline on missing data in confirmatory clinical trials: Specification of mixed models for longitudinal data in study protocols - Häckl - 2019 - Pharmaceutical](https://onlinelibrary.wiley.com/cms/asset/b151f700-70c7-4e06-b999-f13201870f0d/pst.v18.6.cover.jpg)
Empirical evaluation of the implementation of the EMA guideline on missing data in confirmatory clinical trials: Specification of mixed models for longitudinal data in study protocols - Häckl - 2019 - Pharmaceutical
![Per-Treatment Post Hoc Analysis of Clinical Trial Outcomes With Tolvaptan in ADPKD - Kidney International Reports Per-Treatment Post Hoc Analysis of Clinical Trial Outcomes With Tolvaptan in ADPKD - Kidney International Reports](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/5394e17f-9048-4a6e-bdd1-ea00432f34ea/fx1_lrg.jpg)